1 |
Yu W, Shen X, Pan H, Xiao T, Shen P, Xiao Y. Clinical features and treatment of patients with Vibrio vulnificus infection. Int J Infect Dis 2017;59:1-6.
DOI
|
2 |
Lin YS, Hung MH, Chen CC, Huang KF, Ko WC, Tang HJ. Tigecycline salvage therapy for necrotizing fasciitis caused by Vibrio vulnificus: case report in a child. J Microbiol Immunol Infect 2016;49:138-141.
DOI
|
3 |
Kuo Chou TN, Chao WN, Yang C, Wong RH, Ueng KC, Chen SC. Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus. World J Surg 2010;34:1669-1675.
DOI
|
4 |
Chen SC, Chan KS, Chao WN, et al. Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: a 10-yr retrospective study. Crit Care Med 2010;38:1984-1990.
DOI
|
5 |
Kim DM, Jung SI, Jang HC, et al. Vibrio vulnificus DNA load and mortality. J Clin Microbiol 2011;49:413-415.
DOI
|
6 |
Lee JY, Kim DM, Yun NR, et al. Tumor necrosis factor- and mortality in patients infected with Vibrio vulnificus. Am J Trop Med Hyg 2011;84:426-428.
DOI
|
7 |
Centers for Disease Control and Prevention. Summary of human Vibrio isolates reported to CDC, 2004 [Internet]. Atlanta (GA): CDC, 2004 [cited 2018 May 21]. Available from: https://www.cdc.gov/nationalsurveillance/pdfs/vibrio2004.pdf.
|
8 |
Bross MH, Soch K, Morales R, Mitchell RB. Vibrio vulnificus infection: diagnosis and treatment. Am Fam Physician 2007;76:539-544.
|
9 |
Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food: 10 States, United States, 2005. MMWR Morb Mortal Wkly Rep 2006;55:392-395.
|
10 |
Hsueh PR, Lin CY, Tang HJ, et al. Vibrio vulnificus in Taiwan. Emerg Infect Dis 2004;10:1363-1368.
DOI
|
11 |
Haq SM, Dayal HH. Chronic liver disease and consumption of raw oysters: a potentially lethal combination: a review of Vibrio vulnificus septicemia. Am J Gastroenterol 2005;100:1195-1199.
DOI
|
12 |
Daniels NA. Vibrio vulnificus oysters: pearls and perils. Clin Infect Dis 2011;52:788-792.
DOI
|
13 |
Johnston JM, Becker SF, McFarland LM. Vibrio vulnificus. Man and the sea. JAMA 1985;253:2850-2853.
DOI
|
14 |
Barton JC, Acton RT. Hemochromatosis and Vibrio vulnificus wound infections. J Clin Gastroenterol 2009;43:890-893.
DOI
|
15 |
Park SD, Lee JY, Kim HD, Yoon NH. Clinical study of Vibrio vulnificus sepsis. Korean J Dermatol 2006;44:696-707.
|
16 |
Wright AC, Simpson LM, Oliver JD. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun 1981;34:503-507.
|
17 |
Lesic B, Foulon J, Carniel E. Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica. Antimicrob Agents Chemother 2002;46:1741-1745.
DOI
|
18 |
Neupane GP, Kim DM. Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus. Transfusion 2009;49:1762-1769.
DOI
|
19 |
Lee SH, Chung BH, Lee WC. Retrospective analysis of epidemiological aspects of Vibrio vulnificus infections in Korea in 2001-2010. Jpn J Infect Dis 2013;66:331-333.
DOI
|
20 |
Shin YH, Lee JK, Oh KS, et al. National surveillance of Vibrio vulnificus infections in 1998. Korean J Infect Dis 1999;31:232-236.
|
21 |
Kim DM, Hong SJ. Vibrio vulnificus sepsis. Korean J Med 2012;82:671-679.
DOI
|
22 |
Kim CS, Bae EH, Ma SK, Kim SW. Severe septicemia, necrotizing fasciitis, and peritonitis due to Vibrio vulnificus in a patient undergoing continuous ambulatory peritoneal dialysis: a case report. BMC Infect Dis 2015;15:422.
DOI
|
23 |
Chuang YC, Yuan CY, Liu CY, Lan CK, Huang AH. Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 1992;15:271-276.
DOI
|
24 |
Yun NR, Kim DM, Lee J, Han MA. pH level as a marker for predicting death among patients with Vibrio vulnificus infection, South Korea, 2000-2011. Emerg Infect Dis 2015;21:259-264.
DOI
|
25 |
Ok HS, Kim BK, Kim KH, et al. Vertebral osteomyelitis resulting from hematogenous spread of Vibrio vulnificus gastroenteritis. Korean J Med 2014;86:519-522.
DOI
|
26 |
Shapiro RL, Altekruse S, Hutwagner L, et al. The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group. J Infect Dis 1998;178:752-759.
DOI
|
27 |
Klontz KC, Lieb S, Schreiber M, Janowski HT, Baldy LM, Gunn RA. Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med 1988;109:318-323.
DOI
|
28 |
Chen Y, Satoh T, Tokunaga O. Vibrio vulnificus infection in patients with liver disease: report of five autopsy cases. Virchows Arch 2002;441:88-92.
DOI
|
29 |
Merkel SM, Alexander S, Zufall E, Oliver JD, Huet-Hudson YM. Essential role for estrogen in protection against Vibrio vulnificus-induced endotoxic shock. Infect Immun 2001;69:6119-6122.
DOI
|
30 |
Dechet AM, Yu PA, Koram N, Painter J. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006. Clin Infect Dis 2008;46:970-976.
DOI
|
31 |
Tacket CO, Brenner F, Blake PA. Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis 1984;149:558-561.
DOI
|
32 |
Ma KA, Lee SM, Kim MS, et al. Emergency debridement with empirical antibiotics treatment for clinically diagnosed Vibrio sepsis. Korean J Infect Dis 1997;29:297-303.
|
33 |
Lee JY, Kim SW, Kim DM, Yun NR, Kim CM, Lee SH. Clinical usefulness of real-time polymerase chain reaction for the diagnosis of Vibrio vulnificus infection using skin and soft tissues. Am J Trop Med Hyg 2017;97:443-446.
DOI
|
34 |
Kim HS, Kim DM, Neupane GP, et al. Comparison of conventional, nested, and real-time PCR assays for rapid and accurate detection of Vibrio vulnificus. J Clin Microbiol 2008;46:2992-2998.
DOI
|
35 |
Ryu HH, Lee JY, Yun NR, Kim DM. Necrotizing soft tissue infection with gas formation caused by Vibrio vulnificus and misdiagnosed as Pseudomonas aeruginosa. Am J Emerg Med 2013;31:464.
|
36 |
Halow KD, Harner RC, Fontenelle LJ. Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention. J Am Coll Surg 1996;183:329-334.
|
37 |
Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 1998;64:397-400.
|
38 |
McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 1995;221:558-563.
DOI
|
39 |
Han F, Walker RD, Janes ME, Prinyawiwatkul W, Ge B. Antimicrobial susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus isolates from Louisiana Gulf and retail raw oysters. Appl Environ Microbiol 2007;73:7096-7098.
DOI
|
40 |
Chao WN, Tsai CF, Chang HR, et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am J Surg 2013;206:32-39.
DOI
|
41 |
Bowdre JH, Hull JH, Cocchetto DM. Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline. J Pharmacol Exp Ther 1983;225:595-598.
|
42 |
Chuang YC, Liu JW, Ko WC, Lin KY, Wu JJ, Huang KY. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother 1997;41:2214-2217.
DOI
|
43 |
Tang HJ, Chang MC, Ko WC, Huang KY, Lee CL, Chuang YC. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus. Antimicrob Agents Chemother 2002;46:3580-3584.
DOI
|
44 |
Kim DM, Lym Y, Jang SJ, et al. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus. Antimicrob Agents Chemother 2005;49:3489-3491.
DOI
|
45 |
Jang HC, Choi SM, Kim HK, et al. In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis. PLoS One 2014;9:e101118.
DOI
|
46 |
Centers for Disease Control and Prevention. Vibrio vulnificus: general information [Internet]. Atlanta (GA): CDC, 2018 [cited 2018 May 21]. Available from: https://www.cdc.gov.
|
47 |
Chen SC, Lee YT, Tsai SJ, et al. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period. J Antimicrob Chemother 2012;67:488-493.
DOI
|
48 |
Trinh SA, Gavin HE, Satchell KJF. Efficacy of ceftriaxone, cefepime, doxycycline, ciprofloxacin, and combination therapy for Vibrio vulnificus foodborne septicemia. Antimicrob Agents Chemother 2017;61:e01106-17.
|